Unlock instant, AI-driven research and patent intelligence for your innovation.

Thiazole derivatives as dhodh inhibitors and their use

A technology for drugs and uses, applied in the field of thiazole derivatives, can solve problems such as thrombocytopenia

Inactive Publication Date: 2016-10-12
EAST CHINA UNIV OF SCI & TECH
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned drugs all have side effects such as diarrhea, rash, high blood pressure, and disturbance of the liver enzyme system. Taking Buquina together with cyclosporine A or cisplatin may cause mucositis and thrombocytopenia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Thiazole derivatives as dhodh inhibitors and their use
  • Thiazole derivatives as dhodh inhibitors and their use
  • Thiazole derivatives as dhodh inhibitors and their use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Example 1: Synthesis method of compound 1-18:

[0063]

[0064] Dissolve ethyl chloroacetoacetate (9.52g, 57.84mmol) in 100mL ethanol, add thioacetamide (4.8g, 63.9mmol) under stirring, heat to reflux temperature, stir and reflux for 2h, when the reaction is over, The solvent was removed from the reaction solution under reduced pressure to obtain 9.80 g of an orange-pink solid with a yield of 91.1%, which was directly used in the next reaction.

[0065] Weigh LiOH.H 2 O (1.25g, 29.7mmol) was dissolved in 50mL of water, and the ester (2.5g, 13.5mmol) synthesized by one-step reaction was added under stirring. The temperature was raised to 90°C. As the reaction progressed, the solid gradually dissolved. The reaction was stopped after 1 hour. The pH of the reaction solution was adjusted to neutral and slightly acidic with dilute hydrochloric acid, and a large amount of solid was precipitated. The filter cake was washed with water and dried to obtain 2.05 g of light yellow solid ...

Embodiment 2

[0126] Example 2: General synthesis method of compound 19-46:

[0127] Synthesis of thiourea

[0128]

[0129] Dissolve the aromatic amine (8mmol, 1eq) in 24mL of acetone, add the weighed triethylenediamine (24mmol, 3eq) under stirring conditions, then add 20mL of carbon disulfide dropwise, a large amount of solids appear, continue to stir at room temperature for 24h, and filter the reaction The filter cake was washed with petroleum ether. After drying, the filter cake was dissolved in 50 mL of chloroform, and BTC (2.7 mmol, 0.33 eq) was weighed and dissolved in 30 mL of chloroform. The mixture was added dropwise to the reaction solution within 1 hour, and the mixture was stirred at room temperature. Solution overnight. After the completion of the reaction, the reaction solution was suction filtered, the filter cake was washed with dichloromethane, and the obtained filtrate was directly added with silica gel and spin-dried, followed by dry loading (PE elution).

[0130] Dissolve NC...

Embodiment 3

[0222] Example 3: Synthesis of compounds 47-63, 64, 65, 77, 89-92

[0223] Compounds 47-48, 50-52, 55-59, 61-62, 89-92 can be synthesized according to the following scheme.

[0224]

[0225] Synthesis method: Dissolve 1mmol of substituted phenylthiourea and 1mmol of 2-chloroacetylacetone (ethyl 2-chloroacetoacetate) in 20mL methanol, reflux overnight, spin dry methanol, add a small amount of dilute potassium carbonate aqueous solution to neutralize and saturate Wash with brine, extract with ethyl acetate, concentrate and dry the organic layer by column chromatography to obtain the product.

[0226] Target compound spectrum data

[0227] 2-(3,4-Methylanilino)-4-methyl-5-acetylthiazole (Compound 47)

[0228]

[0229] 1 H NMR (400MHz, DMSO) δ (ppm): 7.32 (d, J = 8.0 Hz, 1H), 7.28 (s, 1H), 7.11 (d, J = 8.4 Hz, 1H), 2.53 (s, 3H), 2.41 (s, 3H), 2.21 (s, 3H), 2.18 (s, 3H). HRMS(ESI)calcd for C 14 H 16 N 2 OS(M+H + )261.1062, found 261.1065.

[0230] 2-(4-Methyl-3-chloroanilino)-4-methyl-5-ac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a thiazole derivative, as represented in formula I, as a DHODH inhibitor and a use thereof. The compound of the present invention can be used for treating or preventing DHODH-mediated diseases, including, but not limited to, rheumatoid arthritis and autoimmune diseases such as anti-tumor, anti-organ transplant rejection, and anti-psoriasis.

Description

Technical field [0001] The invention belongs to the fields of medicinal chemistry and pharmacotherapy, and specifically relates to thiazole derivatives as DHODH inhibitors and applications thereof. Background technique [0002] Dihydroorotate dehydrogenase (DHODH) inhibitors mainly act on related cells of the immune system to produce related biological effects, and reduce the activity and number of immune-activated T-lymphocytes and B-lymphocytes by inhibiting the de novo synthesis of pyrimidine. And the cell cycle is blocked in G1 / S phase. [0003] Dihydroorotate dehydrogenase (DHODH) inhibitors are the targets of anti-rheumatoid arthritis, anti-tumor, anti-organ transplant rejection, anti-psoriasis and other autoimmune diseases. DHODH inhibitors are also used As an antibiotic to inhibit Helicobacter pylori and antifungal agent. The role of these inhibitors is to inhibit the rate-controlling step of pyrimidine biosynthesis. In this step of the reaction, dihydroorotic acid is ox...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D275/02C07D401/02C07D417/12C07D401/12A61K31/426A61K31/435A61P19/02A61P35/00A61P37/06A61P37/00A61P17/06
CPCC07D277/42C07D277/46C07D277/56C07D417/06C07D417/12A61P13/12A61P17/06A61P19/02A61P29/00A61P35/00A61P37/00A61P37/02A61P37/06
Inventor 赵振江黄瑾李洪林徐玉芳朱丽丽韩乐许鸣豪高瑞刁妍妍朱俊生曹贤文崔坤强
Owner EAST CHINA UNIV OF SCI & TECH